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STEVIA, CYCLAMATE AND SACCHARIN —  
NATURAL AND ARTIFICIAL SWEETENERS —  
EXERT NO EFFECT ON SULFANE LEVELS IN TISSUES
Abstract: The interactions among natural and artificial sweeteners and endogenous sulfur metabolism 
have never been investigated. CBA strain mice were administered orally stevia, cyclamate or saccha-
rin in doses of 5 mg/kg of body weight in water solutions each. The measurements of the free and 
acid-labile sulfane (H2S) tissue concentrations in brain, heart, liver and kidney were performed with 
Siegel spectrophotometric modified method. No differences in comparisons between hydrogen sulfide 
concentrations in the control group and each sweetener group within every tissue type were noted. 
In conclusion, stevia, cyclamate and saccharine do not change the endogenous sulfur metabolism to 
the extent of causing sulfane tissue levels alterations.
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INTRODUCTION
Hydrogen sulfide, sulfane (H2S) functions as a gaseous intacellular and intercel-
lular signal molecule in mammalian tissues. H2S participates in the regulation of 
various physiological processes including smooth muscle tone control, hormones 
secretion, neurotransmission, cell death and survival, and many pathological 
conditions [1]. Recently, sulfane metabolism alterations have been disclosed in 
the development and progression of type 1 and type 2 diabetes mellitus [2, 3].
Intake of added sugars in Western societies diet is high and has been linked 
to weight gain and adverse effects on glycemic control and diabetes. Among 
many strategies considered to achieve this reduction is substitution with non-
nutritive sweeteners (NNS — artificial sweeteners and stevia) [4]. Apart from 
sugar intake decrease, some NNS have been reported to express other biological 
properties including antihyperglycemic, antihypertensive and anti-inflammatory 
actions [5–7]. Their biological mechanisms are not clear. The interaction between 
NNS and H2S metabolism is hypothesized.
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THE AIM OF THE STUDY
The aim of the study is to assess the influence of artificial sweeteners and stevia 
on the endogenous tissue sulfane concentrations in mouse brain, heart, liver 
and kidney.
MATERIAL AND METHODS
Twenty eight CBA female mice (7-week-old individuals) of approximate 20 g weight 
were involved in the study. The animals were housed under standard laboratory 
conditions and had free access to water and food. They were kept at tempera-
ture of 22–24oC with a light/dark cycle of 12 h (8 am–8 pm and 8 pm–8 am, 
respectively). 
The study protocol comprised oral administration of stevia 5 mg per kg of 
body weight daily (group D1, n = 7) in a water solution, sodium cyclamate 5 mg 
per kg of body weight daily (group D2, n = 7) in a water solution and saccha-
rin 5 mg per kg of body weight daily (group D3, n = 7) in a water solution for 
5 consecutive days at the same time of the day (9:00 am) — each administration 
of 0.1 ml. The control group (n = 7) received orally physiological saline in portions 
of the same volume. The individuals were randomly assigned to each group. The 
animals tolerated the applied solutions well and remained in good condition till 
the end of the experiment. Measurements of the free and acid-labile tissue H2S 
concentrations were performed by the use of the modified method of Siegel [8, 9].
The study has been performed in accordance with the guidelines for the care 
and use of laboratory animals accepted by the Bioethical Committee of the Ja-
giellonian University Medical College (Kraków, Poland).
Two hours after the last injection the animals were killed by cervical disloca-
tion. The brain, heart, kidney and liver tissues of each animal were quickly re-
moved, homogenized with 0.01 M sodium hydroxide (NaOH) and frozen. Each 
tissue was combined with NaOH in different proportions (brain: 1 to 4, kidney 
and liver: 1 to 5 and heart: 1 to 10). Then, 50% trichloroacetic acid (TCA) was 
added to the samples. The TCA solution (0.5 ml) was added to 2 g of brain or 
liver samples in tight 3 ml capsules, and 0.25 ml was added to 1 g of heart or 
kidney sample in tight 2 ml capsules. These suspensions were shaken, and the 
resultant mixture was centrifuged. Subsequently, 1.5 ml brain or liver and 0.75 ml 
heart or kidney supernatant samples were moved to 2 ml tight capsules with 
0.15 ml or 0.075 ml of 0.02 M N,N-dimethyl-p-phenyldiamine sulfate in 7.2 M 
hydrochloric acid (HCl), and 0.15 ml or 0.075 ml of 0.03 M iron (III) chloride 
(FeCl3), respectively, was then added in 1.2 M HCl portions. After 20 min in the 
dark, the contents were shaken for 1 min with 1 ml of chloroform. 
The absorbance was measured at 650 nm with a Varian Cary 100 spectro-
photometer. A standard curve was prepared with an iodometrically determined 
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0.0001 M sodium sulfide (Na2S) solution. Four concurrent analyses of every analy-
zed tissue type were performed for each group of animals.
The statistical analysis was performed with the Statistica 7.1 PL version (Stat-
soft, Tulsa, USA). The Kolmogorov-Smirnov test was applied to examine a normal 
distribution. Subsequently, sulfane sulfur concentrations values between control 
group and each sweetener of every tissue type were compared with the use of 
the Mann-Whitney U test. Statistical significance was considered when p <0.05.
RESULTS
There were no significant changes of sulfane levels following stevia, cyclamate 
and saccharine administration in brain, heart, liver and kidney (Tab. 1).
T a b l e  1
Sulfane tissue concentrations in mouse brain, heart, liver and kidney following the administration 
of stevia, cyclamate and saccharin in equivalent daily doses of 5 mg/kg b.w. per day.  
Values of in each column p concern comparisons of the given sweetener with the control group.
Sulfane tissue 
concentration 
[μg/g]
Control group 
(n = 7)
Stevia 
(n = 7)
Cyclamate 
(n = 7)
Saccharin 
(n = 7)
Brain 2.13 ± 0.05
2.12 ± 0.03 
p = NS
1.86 ± 0.05 
p = NS
1.87 ± 0.04 
p = NS
Heart 3.06 ± 0.06
3.09 ± 0.07 
p = NS
3.32 ± 0.09 
p = NS
2.98 ± 0.08 
p = NS
Liver 2.65 ± 0.07
2.32 ± 0.06 
p = NS
1.92 ± 0.02 
p = NS
2.31 ± 0.03 
p = NS
Kidney 2.18 ± 0.05
1.40 ± 0.03 
p = NS
1.91 ± 0.05 
p = NS
2.36 ± 0.06 
p = NS
DISCUSSION
All NNS bind to, using different binding sites, and activate the sweet receptor 
complex which initiates the sweetness sensation [10]. Sweet taste receptors have 
a two-subunit structure (T1R + T1R3 receptors), associated intracellular effectors 
including phospholipase Cb2 and transient receptor potential cation channel 
subfamily M member 5 (TRPM5) [11]. They are present not only in the mouth 
but throughout the body, especially in endocrine cells of the gastrointestinal 
tract, where they contribute to the expression of glucose transporters, luminal 
glucose sensing, the maintenance of glucose homeostasis, and the release of 
NS — statistically non-significant
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satiety hormones including glucagons-like peptide-1 (GLP-1) [12, 13]. Some NNS 
like contained in stevia stevioside have been shown to suppress inflammatory 
cytokines production through downregulation of nuclear factor-kB (NF-kB) and 
mitogen-activated protein kinases (MAPK) signaling pathways [14]. NNS also 
affect central dopamine systems [15].
The formation of sulfane in mammalian tissues is catalyzed by cystathionine 
b-synthase (CBS), cystathionine g-lyase (CSE) and 3-mercaptopyruvate sulfurt-
ransferase (3-MST). H2S is also a product of different non-enzymatic reactions 
and is present in tissues in the forms of free H2S and within organized stores 
as cytoplasmatic bound sulfane sulfur and acid-labile sulfur, released under 
specific local pH and reducing conditions. The messenger is lipophilic and easily 
permeates plasma membranes and displays pronounced reducing properties. Pro-
teins structure modification via their sulfhydration caused by H2S serves as an 
important physiologic signal. The gasotransmitter interacts with carbon monoxide 
(CO) and nitric oxide (NO) in numerous ways [1, 16–18]. Endogenous sulfane 
co-regulates insulin secretion [19]. In the study by Okamoto et al. H2S protected 
pancreatic beta-cells from glucotoxicity and prevented the development of type 2 
diabetes [2]. H2S was also shown by to increase insulin receptor sensitivity [20]. 
Treatment with H2S inhibited retinopathy development and attenuated myocar-
dial injury in diabetic rats [21, 22]. Moreover, the most widely used in the treat-
ment of type 2 diabetes oral agent metformin was observed to increase H2S tissue 
levels [23]. Intriguingly, other drugs used commonly in diabetic patients with 
proven clinical benefit, including aspirin, angiotensin converting enzyme inhibitor 
ramipril, dihydropyridine calcium channel blocker amlodypine and atorvastatin, 
also affected H2S organ concentrations [24–27].
H2S in its biological action shares some common aspects with NNS, including 
glycemia and blood pressure affection, hormones release, influence on transient 
receptor potential channels (i.a. TRPM5), NF-kB, MAPK, central dopamine sys-
tems [1, 5–7, 11, 15–17, 28]. In our experiment NNS did not alter H2S tissue 
contain. There was only a decreasing trend in the stevia group in the kidney 
tissue as compared to the control group (1.40 ± 0.03 vs 2.18 ± 0.05, respective-
ly, p = 0.26). Perhaps the doses applied in the study were to low to evoke the 
change. The difference could be clearly defined if groups’ abundance was higher. 
The more reliable explanation is that NNS and H2S in there biological action 
trigger different mechanism but their effects at some stage cross in the complex 
metabolic pathways. 
In conclusion, stevia, cyclamate and saccharine do not change the endogenous 
sulfur metabolism to the extent of causing sulfane tissue levels alterations. 
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